SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-23-000265
Filing Date
2023-06-14
Accepted
2023-06-14 11:32:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2788
  Complete submission text file 0001971857-23-000265.txt   4150
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-23186 | Film No.: 231013422
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 64 MONTAUK AVENUE STONINGTON CT 06378
Business Address
Hutson Nancy J (Reporting) CIK: 0001379222 (see all company filings)

Type: 144